By Josh White
Date: Monday 03 Nov 2025
(Sharecast News) - Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its next-generation antibody-targeted therapy conjugate (ATTC) platform, during its annual research and development update on Monday.
| £2 Million Funding Package | 03-Nov-2025 | 18:28 | RNS |
| Director/PDMR Shareholding | 03-Nov-2025 | 18:25 | RNS |
| Exercise of Options & Blocklisting Application | 03-Nov-2025 | 17:30 | RNS |
| Form 8.3 - Audioboom Group PLC | 03-Nov-2025 | 17:29 | RNS |
| Total Voting Rights | 03-Nov-2025 | 17:23 | RNS |
| EasyHotel CFO Darren Mee resigns | 26-Dec-2014 | Telegraph |
| Scotgold pays off RMB loan | 24-Dec-2014 | The Herald |
| Bowleven facing further delay | 24-Dec-2014 | The Herald |
| Tidal energy developer Atlantis Resources gets t... | 23-Dec-2014 | The Herald |
| Havelock sells Fife HQ and writes down stock | 23-Dec-2014 | The Herald |
| Questor :Optimal Payments | 18-Dec-2014 | Telegraph |
| Questor :Falkland Oil & Gas | 17-Dec-2014 | Telegraph |
| Questor :OPG Power Ventures | 10-Dec-2014 | Telegraph |
| Questor :Quindell | 10-Dec-2014 | Telegraph |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Price | 772.02 |
| Change Today | -0.36 |
| % Change | -0.05 % |
| 03-Nov-25 Close | 772.02 |
You are here: research